National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
Two lung cancer drugs have been made available through NHS Scotland while another drug has been rejected.
A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.
A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.
A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.
US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live.